More than 140 mutations distributed over the RSK2 gene have been identified in individuals with CLS; most of them are deletions or missense mutations that disrupt RSK function (Pereira et al., 2010). This evidence concerns the gene RPS6KA3 and Coffin-Lowry syndrome.